IDH1 and glioblastoma: IDH-mutated astrocytomas typically contain IDH1/2 mutations without 1p/19q codeletion, as well as frequent TP53 mutations and ATRX loss, leading to progression to secondary glioblastomas with distinct epigenetic profiles [15].